Showing results (81-90 of 92) with videos related to
Sort By:
Pageof 10
The Lancet. Respiratory Medicine|July 1, 2022
Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysisMarius M Hoeper, Krit Dwivedi, Christine Pausch, et al.Journal of Magnetic Resonance Imaging : JMRI|May 29, 2026
Longitudinal <sup>1</sup>H and <sup>129</sup>Xe Lung MRI in Patients With Post-COVID Residual Lung AbnormalitiesLaura C Saunders, Guilhem J Collier, Laurie J Smith, et al.American Journal of Respiratory and Critical Care Medicine|July 19, 2022
First Genotype-Phenotype Study in TBX4 Syndrome: Gain-of-Function Mutations Causative for Lung DiseaseMatina Prapa, Mauro Lago-Docampo, Emilia M Swietlik, et al.Ebiomedicine|December 21, 2022
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccinationFelicity Liew, Shubha Talwar, Andy Cross, et al.Chest|March 25, 2023
Longitudinal Lung Function Assessment of Patients Hospitalized With COVID-19 Using <sup>1</sup>H and <sup>129</sup>Xe Lung MRILaura C Saunders, Guilhem J Collier, Ho-Fung Chan, et al.Nature Immunology|April 8, 2024
Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of diseaseFelicity Liew, Claudia Efstathiou, Sara Fontanella, et al.BMJ Open Respiratory Research|September 24, 2021
Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID)Jim M Wild, Joanna C Porter, Philip L Molyneaux, et al.The Lancet. Respiratory Medicine|April 18, 2023
Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort studyCallum Jackson, Iain D Stewart, Tatiana Plekhanova, et al.Ebiomedicine|January 25, 2026
Residual lung abnormality following COVID-19 hospitalisation is characterised by biomarkers of epithelial injuryIain Stewart, Joseph Jacob, Joanna C Porter, et al.ERJ Open Research|October 1, 2024
1-year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort studyOlivia C Leavy, Richard J Russell, Ewen M Harrison, et al.Pageof 10